Company / EPS (Diluted)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.82
FY2025
5-year range
-$1.82 / -$0.89
FY2021-FY2025
Trend
-14.5%
vs FY2024
Sector context
#132 of 159
Health Care
What the data says
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s eps (diluted) of $-1.82 is lower than 83% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 10 years, ranging from $-1.82 in FY2025 to $0.17 in FY2020.
Based on SEC 10-K filings.
-1.82 in FY2025.
Declined from $-1.21 to $-1.82 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 159This company -$1.82 Sector average $1.67
▼
-209.1% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 14.5% year-over-year.
- Ranks #132 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.82 | -14.5% |
| FY2024 | -$1.59 | -31.4% |
| FY2023 | -$1.21 | +13.6% |
| FY2022 | -$1.40 | -57.3% |
| FY2021 | -$0.89 | -623.5% |
| FY2020 | $0.17 | +130.9% |
| FY2019 | -$0.55 | +33.7% |
| FY2018 | -$0.83 | -97.6% |
| FY2017 | -$0.42 | +55.3% |
| FY2016 | -$0.94 | +25.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026